BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31087810)

  • 21. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.
    Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T
    Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis.
    Dotevall L; Hagberg L; Karlsson JE; Rosengren LE
    Eur J Neurol; 1999 Mar; 6(2):169-78. PubMed ID: 10053229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
    Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
    Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical aftermath of amateur boxing.
    Zetterberg H; Hietala MA; Jonsson M; Andreasen N; Styrud E; Karlsson I; Edman A; Popa C; Rasulzada A; Wahlund LO; Mehta PD; Rosengren L; Blennow K; Wallin A
    Arch Neurol; 2006 Sep; 63(9):1277-80. PubMed ID: 16966505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.
    Axelsson M; Malmeström C; Nilsson S; Haghighi S; Rosengren L; Lycke J
    J Neurol; 2011 May; 258(5):882-8. PubMed ID: 21197541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients.
    Lejon V; Rosengren LE; Buscher P; Karlsson JE; Sema HN
    Am J Trop Med Hyg; 1999 Jan; 60(1):94-8. PubMed ID: 9988330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair.
    Merisson E; Mattsson N; Zetterberg H; Blennow K; Pikwer A; Mehmedagic I; Acosta S; Åkeson J
    Neurochem Int; 2016 Feb; 93():1-5. PubMed ID: 26682901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma.
    Guéz M; Hildingsson C; Rosengren L; Karlsson K; Toolanen G
    J Neurotrauma; 2003 Sep; 20(9):853-8. PubMed ID: 14577863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
    Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisakk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather LE; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
    Neurology; 2024 Jul; 103(2):e209506. PubMed ID: 38896810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury.
    Shahim P; Tegner Y; Gustafsson B; Gren M; Ärlig J; Olsson M; Lehto N; Engström Å; Höglund K; Portelius E; Zetterberg H; Blennow K
    JAMA Neurol; 2016 Nov; 73(11):1308-1315. PubMed ID: 27654934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome.
    Petzold A; Brettschneider J; Jin K; Keir G; Murray NM; Hirsch NP; Itoyama Y; Reilly MM; Takeda A; Tumani H
    Muscle Nerve; 2009 Jul; 40(1):42-9. PubMed ID: 19533642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.
    Studahl M; Rosengren L; Günther G; Hagberg L
    J Neurol; 2000 Aug; 247(8):636-42. PubMed ID: 11041333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.
    Green AJ; Giovannoni G; Hall-Craggs MA; Thompson EJ; Miller RF
    Sex Transm Infect; 2000 Dec; 76(6):443-6. PubMed ID: 11221126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study.
    Shahim P; Arnell P; Kvarnström A; Rosén A; Bremell D; Hagberg L; Blennow K; Zetterberg H
    Diving Hyperb Med; 2015 Dec; 45(4):240-3. PubMed ID: 26687311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum GFAP as a biomarker for disease severity in multiple sclerosis.
    Abdelhak A; Huss A; Kassubek J; Tumani H; Otto M
    Sci Rep; 2018 Oct; 8(1):14798. PubMed ID: 30287870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.
    Tullberg M; Rosengren L; Blomsterwall E; Karlsson JE; Wikkelsö C
    Neurology; 1998 Apr; 50(4):1122-7. PubMed ID: 9566405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.